[SFConservative]

The question is this -— which one does it better at a cheaper price? leronlimab, or hydroxychloroquine?

I have the impression that most of these biologics ending in "mab" run on the order of $3K per month and I suspect that there is limited production capacity. So hydroxychloroquine should be much more attractive in a pandemic, unless you are a Big Pharma company.

[Mom MD]

unless the biological has a clear treatment advantage. How do we find this out? randomized double blind studies